Hypoxia and metastasis in breast cancer

Current Topics in Microbiology and Immunology

Volumn 345, Issue 1, 2010, Pages 121-139

  Rundqvist, Helene ^a   Johnson, Randall S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; AN 7; ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; METFORMIN; NITRIC OXIDE; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

ACIDOSIS; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CELL MOTILITY; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DRUG MECHANISM; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HYPOXIA; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR VASCULARIZATION; BREAST TUMOR; CELL HYPOXIA; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CELL HYPOXIA; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASM METASTASIS;

EID: 78349272383     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-77     Document Type: Review

References (156)

1. Alexander NR, Tran NL et al (2006) N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 66(7):3365-3369
2. Aragones J, Schneider M et al (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40(2):170-180 (Pubitemid 351171394)
3. Bartosova M, Parkkila S et al (2002) Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol 197(3):314-321 (Pubitemid 34778301)
4. Belaiba RS, Bonello S et al (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18(12):4691-4697 (Pubitemid 350246672)
5. Bendinelli P, Matteucci E et al (2009) NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol Cancer Res 7(8):1328-1341
6. Berchner-Pfannschmidt U, Tug S et al (2010) Oxygen-sensing under the influence of nitric oxide. Cell Signal 22(3):349-356
7. Blancher C, Moore JW et al (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 30-kinase/Akt signaling pathway. Cancer Res 61(19):7349-7355 (Pubitemid 32946535)
8. Blouw B, Song H et al (2003) The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4(2):133-146 (Pubitemid 37040829)
9. Bondareva A, Downey CM et al (2009) The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One 4 (5):e5620
10. Bos R, Zhong H et al (2001) Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93(4):309-314 (Pubitemid 32219818)
11. Bos R, van der Groep P et al (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6): 1573-1581 (Pubitemid 36297788)
12. Bos R, van Diest PJ et al (2004) Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6(4): R450-R459
13. Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294(5545):1337-1340 (Pubitemid 33063099)
14. Buchler P, Reber HA et al (2009) Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia 11(2):196-206
15. Cannito S, Novo E et al (2008) Redox mechanisms switch on hypoxia-dependent epithelialmesenchymal transition in cancer cells. Carcinogenesis 29(12):2267-2278
16. Chabottaux V, Ricaud S et al (2009) Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vascular architecture. J Cell Mol Med 13(9B):4002-4013
17. Chaudary N, Hill RP (2006) Hypoxia and metastasis in breast cancer. Breast Dis 26:55-64 (Pubitemid 46647414)
18. Chen HH, Su WC et al (2007) Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer. Breast Cancer Res Treat 103(2):167-175 (Pubitemid 46789135)
19. Chen J, Imanaka N et al (2010) Hypoxia potentiates notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 102(2):351-360
20. Chia SK, Wykoff CC et al (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19(16):3660-3668 (Pubitemid 32786278)
21. Currie MJ, Hanrahan V et al (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 57(8):829-834 (Pubitemid 39061431)
22. Dales JP, Garcia S et al (2005) Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 116(5):734-739 (Pubitemid 41099705)
23. Dawson MR, Duda DG et al (2009) VEGFR1-activity-independent metastasis formation. Nature 461(7262):E4; discussion E5
24. del Rey MJ, Izquierdo E et al (2009) Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 60(10):2926-2934
25. Denko NC, Fontana LA et al (2003) Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22(37):5907-5914 (Pubitemid 37176711)
26. Dickson PV, Hamner JB et al (2007) Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 13(13):3942-3950 (Pubitemid 47037602)
27. Dowling RJ, Zakikhani M et al (2007) Metformin inhibits mammalian target of rapamycindependent translation initiation in breast cancer cells. Cancer Res 67(22):10804-10812 (Pubitemid 350145909)
28. Du R, Lu KV et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206-220 (Pubitemid 351318372)
29. Dunn LK, Mohammad KS et al (2009) Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One 4(9):e6896
30. Eger A, Aigner K et al (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24(14):2375-2385 (Pubitemid 40546696)
31. Epstein AC, Gleadle JM et al (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1):43-54 (Pubitemid 32972036)
32. Erler JT, Bennewith KL et al (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440(7088):1222-1226
33. Erler JT, Bennewith KL et al (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15(1):35-44
34. Esteban MA, Tran MG et al (2006) Regulation of E-cadherin expression by VHL and hypoxiainducible factor. Cancer Res 66(7):3567-3575
35. Evans JM, Donnelly LA et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304-1305 (Pubitemid 40813563)
36. Funasaka T, Yanagawa T et al (2005) Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 19(11):1422-1430 (Pubitemid 41279000)
37. Funasaka T, Hogan V et al (2009) Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res 69(13):5349-5356
38. Gallagher SM, Castorino JJ et al (2009) Interaction of monocarboxylate transporter C4 with beta1-integrin and its role in cell migration. Am J Physiol Cell Physiol 296(3):C414-C421
39. Gao CF, Vande Woude GF (2005) HGF/SF-Met signaling in tumor progression. Cell Res 15(1):49-51 (Pubitemid 41653965)
40. Generali D, Berruti A et al (2006) Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12(15):4562-4568 (Pubitemid 44297805)
41. Giatromanolaki A, Koukourakis MI et al (2001) Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61(21):7992-7998 (Pubitemid 33049392)
42. Giatromanolaki A, Sivridis E et al (2006) Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol 14(1):78-82
43. Gonzalez-Moreno O, Lecanda J et al (2010) VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Exp Cell Res 316(4):554-567
44. Goodwin PJ, Pritchard KI et al (2008) Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 8(6):501-505
45. Graham CH, Fitzpatrick TE et al (1998) Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 91(9):3300-3307 (Pubitemid 28193880)
46. Graham CH, Forsdike J et al (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80(4):617-623 (Pubitemid 29047530)
47. Gruber G, Greiner RH et al (2004) Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 6(3):R191-R198
48. Grunert S, Jechlinger M et al (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4(8):657-665 (Pubitemid 36934968)
49. Haase VH (2009) Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int 76(5):492-499
50. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70 (Pubitemid 30046295)
51. Hanna JA, Bordeaux J et al (2009) The function, proteolytic processing, and histopathology of Met in cancer. Adv Cancer Res 103:1-23
52. Harbeck N, Schmitt M et al (2007) Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms. Crit Rev Clin Lab Sci 44(2):179-201
53. Hazan RB, Phillips GR et al (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148(4):779-790
54. Heath VL, Bicknell R (2009) Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 6(7):395-404
55. Hedlund EM, Hosaka K et al (2009) Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature. Proc Natl Acad Sci USA 106(41):17505-17510
56. Hibbs JB Jr., Taintor RR et al (1987) Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235(4787):473-476 (Pubitemid 17009584)
57. Hildenbrand R, Schaaf A (2009) The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Int J Oncol 34(1):15-23
58. Holmquist-Mengelbier L, Fredlund E et al (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10(5):413-423 (Pubitemid 44693470)
59. Huang CH, Yang WH et al (2009) Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 11(12):1371-1382
60. Ivan M, Kondo K et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516):464-468 (Pubitemid 32335941)
61. Jaakkola P, Mole DR et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292(5516):468-472 (Pubitemid 32335942)
62. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58-62 (Pubitemid 40093472)
63. Jedeszko C, Victor BC et al (2009) Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Res 69(23):9148-9155
64. Jiralerspong S, Palla SL et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297-3302
65. Jo M, Lester RD et al (2009) Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J Biol Chem 284(34):22825-22833
66. Kaplan RN, Riba RD et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820-827 (Pubitemid 41753060)
67. Kim MS, Kwon HJ et al (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7(4):437-443 (Pubitemid 32298546)
68. Kim HO, Jo YH et al (2008) The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep 20(5):1181-1187
69. Kirschmann DA, Seftor EA et al (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res 62(15):4478-4483 (Pubitemid 34827311)
70. Kitajima Y, Ide T et al (2008) Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 99(7):1341-1347 (Pubitemid 351761722)
71. Korah R, Boots M et al (2004) Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res 64(13):4514-4522 (Pubitemid 38856923)
72. Koukourakis MI, Giatromanolaki A et al (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumorassociated stroma. Cancer Res 66(2):632-637 (Pubitemid 43165922)
73. Kroon ME, Koolwijk P et al (2000) Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 96(8):2775-2783
74. Kuphal S, Bosserhoff AK (2006) Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 25(2):248-259 (Pubitemid 43083686)
75. Lechner M, Lirk P et al (2005) Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 15(4):277-289 (Pubitemid 41058773)
76. Lee WY, Chen HH et al (2005) Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin Cancer Res 11(6):2222-2228 (Pubitemid 40490180)
77. Leek RD, Lewis CE et al (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56(20):4625-4629 (Pubitemid 26338061)
78. Leong KG, Niessen K et al (2007) Jagged1-mediated notch activation induces epithelial-tomesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204(12):2935-2948 (Pubitemid 350179562)
79. Lester RD, Jo M et al (2007) uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178(3):425-436 (Pubitemid 47196151)
80. Li G, Satyamoorthy K et al (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61(9):3819-3825 (Pubitemid 32694999)
81. Liao D, Corle C et al (2007) Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67(2):563-572 (Pubitemid 46192193)
82. Liao D, Luo Y et al (2009) Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One 4(11):e7965
83. Lin EY, Nguyen AV et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727-740
84. Lin S, Sun L et al (2009) Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. Cancer Lett 279(1):108-117
85. Liu B, Fan Z et al (2009) Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8(13):2031-2040
86. Mahon PC, Hirota K et al (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15(20):2675-2686 (Pubitemid 32988878)
87. Maity A, Solomon D (2000) Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia. Exp Cell Res 255(2):250-257 (Pubitemid 30143858)
88. Martinez-Zaguilan R, Seftor EA et al (1996) Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14(2):176-186 (Pubitemid 26074280)
89. Maxwell PH, Wiesener MS et al (1999) The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399(6733):271-275 (Pubitemid 29246458)
90. Mazzone M, Dettori D et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136(5):839-851
91. Milosevic M, Fyles A et al (2001) Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 61(17):6400-6405 (Pubitemid 32783245)
92. Mottet D, Castronovo V (2008) Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25(2):183-189
93. Muller A, Homey B et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50-56 (Pubitemid 32225831)
94. Naidu R, Har YC et al (2009) Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer. Neoplasma 56(5):441-447
95. Niizeki H, Kobayashi M et al (2002) Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer 86(12):1914-1919
96. Oliveras-Ferraros C, Vazquez-Martin A et al (2009) Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells. Cell Cycle 8(10):1633-1636
97. Orimo A, Gupta PB et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121(3):335-348 (Pubitemid 40692295)
98. Pan Y, Mansfield KD et al (2007) Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 27(3):912-925 (Pubitemid 46174556)
99. Pennacchietti S, Michieli P et al (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3(4):347-361 (Pubitemid 38340304)
100. Petrella BL, Lohi J et al (2005) Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24(6):1043-1052 (Pubitemid 40313881)
101. Phoenix KN, Vumbaca F et al (2009) Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat 113(1):101-111
102. Poellinger L, Johnson RS (2004) HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev 14(1):81-85 (Pubitemid 38167481)
103. Putignani L, Raffa S et al (2008) Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria. Breast Cancer Res Treat 110(3): 439-452 (Pubitemid 351962585)
104. Qing G, Simon MC (2009) Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 19(1):60-66
105. Rankin EB, Rha J et al (2008) Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27(40):5354-5358
106. Rauh MJ, Ho V et al (2005) SHIP represses the generation of alternatively activated macrophages. Immunity 23(4):361-374 (Pubitemid 41443438)
107. Rius J, Guma M et al (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453(7196):807-811 (Pubitemid 351793778)
108. Rizki A, Weaver VM et al (2008) A human breast cell model of preinvasive to invasive transition. Cancer Res 68(5):1378-1387 (Pubitemid 351346845)
109. Rofstad EK, Tunheim SH et al (2002) Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 62(3):661-664 (Pubitemid 34126937)
110. Ruas JL, Poellinger L (2005) Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin Cell Dev Biol 16(4-5):514-522 (Pubitemid 41247874)
111. Sahlgren C, Gustafsson MV et al (2008) Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105(17):6392-6397 (Pubitemid 351758356)
112. Scatena R, Bottoni P et al (2008) Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17(10):1533-1545
113. Schietke RE, Warnecke C et al (2010) The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia -insights into cellular transformation processes mediated by HIF-1. J Biol Chem 26;285(9):6658-6669
114. Schindl M, Schoppmann SF et al (2002) Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8(6):1831-1837 (Pubitemid 34633742)
115. Schioppa T, Uranchimeg B et al (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198(9):1391-1402 (Pubitemid 37392484)
116. Seagroves TN, Ryan HE et al (2001) Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 21(10):3436-3444 (Pubitemid 32381779)
117. Selak MA, Armour SM et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7(1):77-85 (Pubitemid 40126384)
118. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732 (Pubitemid 37328811)
119. Serrati S, Margheri F et al (2008) Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 214(5):545-554 (Pubitemid 351492460)
120. Shackelford DB, Vasquez DS et al (2009) mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci USA 106(27): 11137-11142
121. Song G, Ouyang G et al (2009) Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med 13(8B):1706-1718
122. Spangenberg C, Lausch EU et al (2006) ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. Cancer Res 66(7):3715-3725
123. Staller P, Sulitkova J et al (2003) Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425(6955):307-311 (Pubitemid 37158407)
124. Stockmann C, Doedens A et al (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456(7223):814-818
125. Swinnen JV, Beckers A et al (2005) Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. Cancer Res 65(6):2441-2448 (Pubitemid 40490156)
126. Takeda N, O'Dea EL et al (2010) Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev 24(5):491-501
127. Tan EY, Campo L et al (2007) Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Res 9(6):R89
128. Tanimoto K, Makino Y et al (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19(16):4298-4309 (Pubitemid 30623741)
129. Tarasenko N, Nudelman A et al (2008) Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex). Clin Exp Metastasis 25(7):703-716
130. Tatemichi M, Ogura T et al (2009) Impact of inducible nitric oxide synthase gene on tumor progression. Eur J Cancer Prev 18(1):1-8
131. Tatum JL, Kelloff GJ et al (2006) Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82(10):699-757 (Pubitemid 44832019)
132. Tennant DA, Frezza C et al (2009) Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 28(45):4009-4021
133. Thangasamy A, Rogge J et al (2009) Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. J Biol Chem 284(21):14001-14010
134. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442-454
135. Treins C, Murdaca J et al (2006) AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1. Biochem Biophys Res Commun 342(4):1197-1202
136. Tsutsui S, Yasuda K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14(2): 425-431
137. Tsutsumi S, Yanagawa T et al (2004) Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res 10(22):7775-7784 (Pubitemid 39557543)
138. Ullah MS, Davies AJ et al (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 281(14):9030-9037 (Pubitemid 43864615)
139. van der Groep P, Bouter A et al (2008) High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Cancer Res Treat 111(3):475-480
140. Vaupel P, Kallinowski F et al (1990) Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol 277:895-905
141. Vaupel P, Briest S et al (2002) Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 152(13-14):334-342 (Pubitemid 34824207)
142. Vaupel P, Mayer A et al (2005) Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. Adv Exp Med Biol 566: 333-342 (Pubitemid 43779520)
143. Vazquez-Martin A, Oliveras-Ferraros C et al (2009) The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell Cycle 8(1):88-96
144. Wang GL, Jiang BH et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92(12):5510-5514
145. Weigert A, Brune B (2008) Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19(2):95-102
146. Xie K, Dong Z et al (1996) Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol 59(6):797-803 (Pubitemid 26238474)
147. Yan M, Rayoo M et al (2009) BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer 101(7):1168-1174
148. Yang J, Mani SA et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7):927-939 (Pubitemid 38798858)
149. Yang AD, Camp ER et al (2006) Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66 (1):46-51 (Pubitemid 43166007)
150. Young SD, Hill RP (1990) Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 82(5):371-380 (Pubitemid 20108027)
151. Young SD, Marshall RS et al (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85(24):9533-9537 (Pubitemid 19027161)
152. Yun H, Lee M et al (2005) Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 280(11):9963-9972 (Pubitemid 40395845)
153. Zelzer E, Levy Y et al (1998) Insulin induces transcription of target genes through the hypoxiainducible factor HIF-1alpha/ARNT. EMBO J 17(17):5085-5094 (Pubitemid 28408474)
154. Zhong H, De Marzo AM et al (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59(22):5830-5835
155. Zhuang Y, Miskimins WK (2008) Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 3:18
156. Zinser GM, Leonis MA et al (2006) Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Res 66(24):11967-11974 (Pubitemid 46094210)